Chandrani Mondal

Profiling critical cancer gene mutations in clinical tumor samples.

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.

Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency.

The alternatively-included 11a sequence modifies the effects of Mena on actin cytoskeletal organization and cell behavior.